185 related articles for article (PubMed ID: 34727750)
21. Papillary thyroid carcinoma with a high tumor mutation burden has a poor prognosis.
Xie Z; Li X; Lun Y; He Y; Wu S; Wang S; Sun J; He Y; Xin S; Zhang J
Int Immunopharmacol; 2020 Dec; 89(Pt B):107090. PubMed ID: 33091816
[TBL] [Abstract][Full Text] [Related]
22. The prognostic value of plasma complement factor B (CFB) in thyroid carcinoma.
Wu P; Shi J; Sun W; Zhang H
Bioengineered; 2021 Dec; 12(2):12854-12866. PubMed ID: 34898340
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis and Prognosis of Thyroid Cancer by Immune-related Genes.
Li J; Li Z; Zhao P
Am J Clin Oncol; 2024 Jan; 47(1):1-10. PubMed ID: 37779238
[TBL] [Abstract][Full Text] [Related]
24. Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis.
Reyimu A; Chen Y; Song X; Zhou W; Dai J; Jiang F
World J Surg Oncol; 2021 Aug; 19(1):240. PubMed ID: 34384424
[TBL] [Abstract][Full Text] [Related]
25. Systematic analysis of the prognosis and immune infiltration of E2Fs in thyroid carcinoma.
Fu X; Zhou X; Ji F; He Q; Qiu X
Front Genet; 2023; 14():1215984. PubMed ID: 37560385
[No Abstract] [Full Text] [Related]
26. E2F, HSF2, and miR-26 in thyroid carcinoma: bioinformatic analysis of RNA-sequencing data.
Lu JC; Zhang YP
Genet Mol Res; 2016 Mar; 15(1):15017576. PubMed ID: 26985959
[TBL] [Abstract][Full Text] [Related]
27. A Novel Immune-Related Prognostic Signature for Thyroid Carcinoma.
Xue Y; Li J; Lu X
Technol Cancer Res Treat; 2020; 19():1533033820935860. PubMed ID: 32588760
[TBL] [Abstract][Full Text] [Related]
28. The clinical significance of thyroid hormone-responsive in thyroid carcinoma and its potential regulatory pathway.
Yu ZX; Xiang C; Xu SG; Zhang YP
Medicine (Baltimore); 2022 Aug; 101(31):e29972. PubMed ID: 35945747
[TBL] [Abstract][Full Text] [Related]
29. The downregulation of lncRNA EMX2OS might independently predict shorter recurrence-free survival of classical papillary thyroid cancer.
Gu Y; Feng C; Liu T; Zhang B; Yang L
PLoS One; 2018; 13(12):e0209338. PubMed ID: 30576338
[TBL] [Abstract][Full Text] [Related]
30. lncRNA DUXAP8 inhibits papillary thyroid carcinoma cell apoptosis via sponging the miR‑20b‑5p/SOS1 axis.
Pang R; Yang S
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760128
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the Prognostic Value and Potential Molecular Mechanisms of TREM-1 Overexpression in Papillary Thyroid Cancer
Xie Z; Li X; He Y; Wu S; Wang S; Sun J; He Y; Lun Y; Xin S; Zhang J
Front Endocrinol (Lausanne); 2021; 12():646793. PubMed ID: 34122331
[TBL] [Abstract][Full Text] [Related]
32. DNAJC10 correlates with tumor immune characteristics and predicts the prognosis of glioma patients.
Liu F; Tu Z; Liu J; Long X; Xiao B; Fang H; Huang K; Zhu X
Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34988580
[TBL] [Abstract][Full Text] [Related]
33. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
Guo H; Li C; Su X; Huang X
Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843
[No Abstract] [Full Text] [Related]
34. DPP4 Is a Potential Prognostic Marker of Thyroid Carcinoma and a Target for Immunotherapy.
Gao X; Le Y; Geng C; Jiang Z; Zhao G; Zhang P
Int J Endocrinol; 2022; 2022():5181386. PubMed ID: 36467461
[TBL] [Abstract][Full Text] [Related]
35. LncRNA H19 is a potential biomarker and correlated with immune infiltration in thyroid carcinoma.
Sahin Y
Clin Exp Med; 2023 Jul; 23(3):841-851. PubMed ID: 35810257
[TBL] [Abstract][Full Text] [Related]
36. Development and Validation of Potential Molecular Subtypes and Signatures of Thyroid Carcinoma Based on Aging-related Gene Analysis.
Li Z; Jia LI; Zhou HR; Zhang LU; Zhang M; Lv J; Deng ZY; Liu C
Cancer Genomics Proteomics; 2024; 21(1):102-117. PubMed ID: 38151291
[TBL] [Abstract][Full Text] [Related]
37. Chemokine CCL14 affected the clinical outcome and correlated with immune infiltrates in thyroid carcinoma.
Zhang MM; Zhao YD; Li Q; He YJ
Histol Histopathol; 2023 Jun; 38(6):695-707. PubMed ID: 36409028
[TBL] [Abstract][Full Text] [Related]
38. New insights into COL26A1 in thyroid carcinoma: prognostic prediction, functional characterization, immunological drug target and ceRNA network.
Luo Y; Ye Y; Zhang Y; Chen L; Qu X; Yi N; Ran J; Chen Y
Transl Cancer Res; 2023 Dec; 12(12):3384-3408. PubMed ID: 38197076
[TBL] [Abstract][Full Text] [Related]
39. Upregulated GSDMB in Clear Cell Renal Cell Carcinoma Is Associated with Immune Infiltrates and Poor Prognosis.
Cui Y; Zhou Z; Chai Y; Zhang Y
J Immunol Res; 2021; 2021():7753553. PubMed ID: 34957313
[TBL] [Abstract][Full Text] [Related]
40. Increased SEMA6B expression as a potential prognostic and immune cell infiltration biomarker in thyroid cancer patients.
Lei Q; Wang Y; Li J; Wang S; Hu Y; Duan L; Huo Y; Wu Y; Liu H
Aging (Albany NY); 2023 May; 15(9):3572-3585. PubMed ID: 37155149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
